FdaApplication
NDA 021726
Identifiers
- fda_app_no: NDA021726
Properties
| Property | Value |
|---|---|
| applicant_name | UCB INC |
| application_type | NDA |
| approval_date | 2005-01-19 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NIRAVAM | ALPRAZOLAM | 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
| NIRAVAM | ALPRAZOLAM | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
| NIRAVAM | ALPRAZOLAM | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
| NIRAVAM | ALPRAZOLAM | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
4 products